Black Diamond Therapeutics, Inc. (BDTX) Ownership

$2.71

$0.02 (0.74%)
Last update: 04:00 PM EST
Day's range
$2.48
Day's range
$2.72

Black Diamond Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2025 10.74 M $40.72 M   2.21% 18.91%
VESTAL POINT CAPITAL, LP 11/14/2025 5.55 M $21.03 M   -0.89% 9.77%
NEA MANAGEMENT COMPANY, LLC 11/14/2025 4.45 M $16.86 M   0.00% 7.83%
VANGUARD GROUP INC 11/07/2025 2.19 M $8.30 M   4.08% 3.85%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 2.07 M $7.85 M   0.00% 3.64%
MARSHALL WACE, LLP 11/13/2025 1.30 M $4.92 M   76.07% 2.29%
SIREN, L.L.C. 11/13/2025 1.05 M $3.97 M   0.00% 1.84%
BLACKROCK, INC. 11/12/2025 1.03 M $3.90 M   -5.75% 1.81%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 896.85 K $3.40 M   549.22% 1.58%
MILLENNIUM MANAGEMENT LLC 11/14/2025 850.33 K $3.22 M   -10.00% 1.50%
UBS GROUP AG 11/13/2025 628.42 K $2.38 M   100.32% 1.11%
AWM INVESTMENT COMPANY, INC. 11/13/2025 600.00 K $2.27 M   20.00% 1.06%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 599.40 K $2.27 M   258.71% 1.06%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 500.52 K $1.90 M   1.05% 0.88%
NORTHERN TRUST CORP 11/14/2025 488.06 K $1.85 M   222.32% 0.86%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 481.12 K $1.82 M   100.00% 0.85%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 455.87 K $1.73 M   0.00% 0.80%
FMR LLC 11/13/2025 453.56 K $1.72 M   9.59% 0.80%
GOLDMAN SACHS GROUP INC 11/14/2025 449.02 K $1.70 M   28.06% 0.79%
DAFNA CAPITAL MANAGEMENT LLC 11/14/2025 307.07 K $1.16 M   -34.80% 0.54%
GLOBEFLEX CAPITAL L P 11/12/2025 305.28 K $1.16 M   100.00% 0.54%
JANE STREET GROUP, LLC 11/14/2025 237.27 K $899.27 K   13.81% 0.42%
STIFEL FINANCIAL CORP 11/12/2025 222.25 K $842.31 K   1.05% 0.39%
XTX TOPCO LTD 11/14/2025 216.20 K $819.38 K   20.62% 0.38%
STATE STREET CORP 11/14/2025 213.51 K $809.21 K   0.00% 0.38%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 11/14/2025 211.08 K $800.00 K   269.39% 0.37%
TD ASSET MANAGEMENT INC 11/10/2025 183.42 K $695.16 K   10.71% 0.32%
D. E. SHAW & CO., INC. 11/14/2025 143.64 K $544.41 K   702.47% 0.25%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11/13/2025 142.44 K $539.84 K   100.00% 0.25%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 131.64 K $498.90 K   100.00% 0.23%
KENNEDY CAPITAL MANAGEMENT LLC 11/13/2025 129.94 K $492.49 K   97.26% 0.23%
BANK OF NEW YORK MELLON CORP 11/03/2025 125.67 K $476.30 K   0.00% 0.22%
GSA CAPITAL PARTNERS LLP 11/07/2025 122.76 K $465.00 K   -48.85% 0.22%
RITHOLTZ WEALTH MANAGEMENT 10/28/2025 101.48 K $384.61 K   100.00% 0.18%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 98.30 K $372.56 K   0.00% 0.17%
INVESCO LTD. 11/13/2025 95.34 K $361.35 K   58.35% 0.17%
AMERICAN CENTURY COMPANIES INC 11/12/2025 92.43 K $350.31 K   661.11% 0.16%
MAN GROUP PLC 11/14/2025 78.33 K $296.86 K   88.39% 0.14%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 78.27 K $296.63 K   17.78% 0.14%
LPL FINANCIAL LLC 11/12/2025 69.24 K $262.42 K   -16.52% 0.12%
MORGAN STANLEY 11/14/2025 69.14 K $262.03 K   -23.45% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 68.70 K $260.37 K   100.00% 0.12%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 11/12/2025 64.52 K $245.00 K   100.00% 0.11%
HILLSDALE INVESTMENT MANAGEMENT INC. 11/10/2025 63.62 K $241.13 K   100.00% 0.11%
BANK OF AMERICA CORP /DE/ 11/14/2025 43.36 K $164.33 K   22.53% 0.08%
GRAHAM CAPITAL MANAGEMENT, L.P. 11/14/2025 36.52 K $138.42 K   -49.29% 0.06%
CATALYST FUNDS MANAGEMENT PTY LTD 11/12/2025 27.80 K $105.36 K   50.27% 0.05%
HSBC HOLDINGS PLC 11/13/2025 26.42 K $97.76 K   -36.64% 0.05%
STATE OF WYOMING 11/04/2025 24.29 K $92.07 K   100.00% 0.04%
KATHMERE CAPITAL MANAGEMENT, LLC 10/22/2025 24.28 K $92.03 K   100.00% 0.04%

Black Diamond Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 129 institutional investors and hedge funds held shares of Black Diamond Therapeutics, Inc.. The most heavily invested institutionals were:

T. Rowe Price Investment Management, Inc.: 10.74 M

Vestal Point Capital, LP: 5.55 M

NEA Management Company, LLC: 4.45 M

VANGUARD GROUP INC: 2.19 M

TANG CAPITAL MANAGEMENT LLC: 2.07 M

MARSHALL WACE, LLP: 1.3 M

68.27% of Black Diamond Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 43.83 M shares in the last 24 months. This purchase volume represents approximately $118.79 M in transactions.